IRIS Accounts Production v24.1.0.578 14428227 director 19.10.22 31.12.23 31.12.23 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh144282272022-10-18144282272023-12-31144282272022-10-192023-12-31144282272022-10-1814428227ns15:EnglandWales2022-10-192023-12-3114428227ns14:PoundSterling2022-10-192023-12-3114428227ns10:Director12022-10-192023-12-3114428227ns10:PrivateLimitedCompanyLtd2022-10-192023-12-3114428227ns10:Micro-entities2022-10-192023-12-3114428227ns10:AuditExempt-NoAccountantsReport2022-10-192023-12-3114428227ns10:FullAccounts2022-10-192023-12-3114428227ns10:RegisteredOffice2022-10-192023-12-3114428227ns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 14428227 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 19TH OCTOBER 2022 TO 31ST DECEMBER 2023

FOR

NVA BIOTECH CO LTD

NVA BIOTECH CO LTD (BY SHARES) (REGISTERED NUMBER: 14428227)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 19TH OCTOBER 2022 TO 31ST DECEMBER 2023










Page

Company Information 1

Balance Sheet 2


NVA BIOTECH CO LTD (BY SHARES)

COMPANY INFORMATION
FOR THE PERIOD 19TH OCTOBER 2022 TO 31ST DECEMBER 2023







DIRECTOR: Miss N Aleshkina





REGISTERED OFFICE: 129 Doulton House
11 Park Street
London
SW6 2FT





REGISTERED NUMBER: 14428227 (England and Wales)





ACCOUNTANTS: R Pau & Co Limited
Chartered Certified Accountants
12-16 Station Street East
Coventry
West Midlands
CV6 5FJ

NVA BIOTECH CO LTD (BY SHARES) (REGISTERED NUMBER: 14428227)

BALANCE SHEET
31ST DECEMBER 2023

£   
CURRENT ASSETS 9,157

CREDITORS
Amounts falling due within one year (5,907 )
NET CURRENT ASSETS 3,250
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,250

CAPITAL AND RESERVES 3,250

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was NIL.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31st December 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31st December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 15th April 2024 and were signed by:





Miss N Aleshkina - Director